LUNA MEDICAL TECHNOLOGIES INC
10KSB, EX-27, 2000-07-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: LUNA MEDICAL TECHNOLOGIES INC, 10KSB, EX-23.1, 2000-07-14
Next: TELECORP PCS INC, 8-K, 2000-07-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the audited
Consolidated Balance Sheet as at March 31, 2000 and the audited Consolidated
Statement of Operations and Comprehensive Income for the twelve month period
ended March 31, 2000 and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         63403
<SECURITIES>                                   0
<RECEIVABLES>                                  2081
<ALLOWANCES>                                   (1375)
<INVENTORY>                                    223
<CURRENT-ASSETS>                               84229
<PP&E>                                         6045
<DEPRECIATION>                                 (504)
<TOTAL-ASSETS>                                 92271
<CURRENT-LIABILITIES>                          90898
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       8041
<OTHER-SE>                                     (6668)
<TOTAL-LIABILITY-AND-EQUITY>                   92271
<SALES>                                        111712
<TOTAL-REVENUES>                               111712
<CGS>                                          75134
<TOTAL-COSTS>                                  75134
<OTHER-EXPENSES>                               451897
<LOSS-PROVISION>                               1375
<INTEREST-EXPENSE>                             2588
<INCOME-PRETAX>                                (419282)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (419282)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (419282)
<EPS-BASIC>                                    (0.06)
<EPS-DILUTED>                                  (0.06)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission